Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-24
1997-10-07
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514414, 546122, 548453, A61K 3149, C07D47108, C07D48708
Patent
active
056748779
ABSTRACT:
Described herein are D4 receptor-selective compounds of the general formula I: ##STR1## wherein: A and B are independently selected, optionally substituted, saturated or unsaturated 5- or 6-membered, homo- or heterocyclic rings;
REFERENCES:
patent: 3539573 (1970-11-01), Schmutz et al.
patent: 3546226 (1970-12-01), Schmutz et al.
patent: 3751415 (1973-08-01), Schmutz et al.
patent: 3758479 (1973-09-01), Schmutz et al.
patent: 3908010 (1975-09-01), Schmutz et al.
patent: 3983234 (1976-09-01), Sayers
patent: 4096261 (1978-06-01), Horrom et al.
patent: 5006522 (1991-04-01), Engel et al.
patent: 5354747 (1994-10-01), Hansen, Jr. et al.
Bloom et al., J. Pharmacology and Experimental Therapeutics, 1987, Receptors in Rabbit Peripheral Lung".
Clark et al., J. Med. Chem., 1993, 36:2645 Potent Conformationally Restricted 5-HT.sub.3 Receptor Antagonists".
Giani et al. Synthesis, 1985, p. 550 "A New Facile Synthesis of
Harden et al. TIPS, Feb. 1986 Supplement "Characteristics of two biochemical responses to stimulation of muscarinic cholinergic receptors".
Harris et al. J. Med. Chem., 1982, 25:855 "Affinity of Binding Sites in Rat Brain".
Jaen et al. Annual Reports in Medicinal Chemistry-29, p. 23 "Recent Advances in the Design and Characterization of Muscarinic Agonists and Antagonists".
Jones et al. Life Sciences, 1993, 52:457 "Muscarinic Receptor Subtypes: Modulation of Ion Channels".
Kaiser et al. Neurotransmissions, 1987, vol. III, No. 2 "Cholinergic Agents".
Klunder et al. J. Med. Chem., 1992, 35:1887 "Novel Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2. Tricyclic Pyridobenzoxazepinones and Dibenzoxazepinones".
dePaulis et al. J. Med. Chem., 1981, 24(9):1021 "Synthesis of Clozapine Analogues and Their Affinity for Clozapine and Spiroperidol Binding Sites in Rat Brain".
Sindelair et al. Coll. Czechoslov. Chem. Commun., 1977, 42:2231 "noncataleptic Potential Neuroleptics: 2-Nitro and 2-Hydroxy derivatives
Watson et al. Trends Pharmacol. Sci., Suppl. 7, 1986, p. 46 "Biochemical and functional basis of putative muscarinic receptor subtypes and its implications".
Rakhit Sumanas
Tehim Ashok
Allelix Biopharmaceuticals Inc.
Datlow Philip I.
LandOfFree
Muscarinic receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357598